In particular, cancer cells activate the production of the NF-κB regulated paracrine factor RANKL (Receptor Activator of NF-κB Ligand) in stromal cells which in turn pathologically increases osteoclasts activity and bone resorption, both hallmarks of bone metastases and critical for metastatic establishment and progression [47,48]. The gene discussed is NFKB1; the disease is cancer.